We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 2,667 results
  1. Salivary Proteomic Analysis of Canine Oral Melanoma by MALDI-TOF Mass Spectrometry and LC-Mass Spectrometry/Mass Spectrometry

    Canine oral melanoma (COM) is a common oral cancer with aggressiveness and high metastasis. A tumor in a dog’s mouth makes it difficult to be...
    Sekkarin Ploypetch, Sittiruk Roytrakul, Gunnaporn Suriyaphol in Melanoma
    Protocol 2021
  2. The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells

    Abstract

    Acidosis characterizes the microenvironment of most solid tumors and is considered a new hallmark of cancer. It is mainly caused by both...

    Elena Andreucci, Silvia Peppicelli, ... Lido Calorini in Journal of Molecular Medicine
    Article Open access 15 August 2020
  3. Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

    Personal neoantigen vaccines have been envisioned as an effective approach to induce, amplify and diversify antitumor T cell responses. To define the...

    Zhuting Hu, Donna E. Leet, ... Patrick A. Ott in Nature Medicine
    Article 21 January 2021
  4. Integrin-Src-YAP1 signaling mediates the melanoma acquired resistance to MAPK and PI3K/mTOR dual targeted therapy

    Activation of PI3K/AKT pathway is one of the most recurrent resistant mechanisms for BRAF-targeted therapy, and the combination of MAPK and PI3K/AKT...

    Chune Yu, Min Zhang, ... Hubing Shi in Molecular Biomedicine
    Article Open access 10 November 2020
  5. A novel chalcone derivative suppresses melanoma cell growth through targeting Fyn/Stat3 pathway

    Background

    Fyn has been documented to have oncogenic features in multiple tumors, which might be a potential therapeutic target, however, few studies...

    Ling Tang, **g Long, ... Cong Peng in Cancer Cell International
    Article Open access 18 June 2020
  6. Circ_0119872 promotes uveal melanoma development by regulating the miR-622/G3BP1 axis and downstream signalling pathways

    Background

    The abnormal expression of circular RNAs (circRNAs) in uveal melanoma (UM) has been revealed, but the specific underlying molecular...

    Shuting Liu, Liang Chen, ... Mingchang Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 12 February 2021
  7. Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level

    Purpose

    Upregulation of receptor tyrosine kinase EphA2 has been found to be associated with a poor prognosis in many types of cancer and is considered...

    **g Mo, **ulan Zhao, ... Baocun Sun in Cellular Oncology
    Article 14 April 2020
  8. PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

    Melanoma is the main cause of death among skin cancers and its incidence worldwide has been experiencing an appalling increase. However, traditional...

    Lorena Gonzalez-Melero, Edorta Santos-Vizcaino, ... Rosa Maria Hernandez in Drug Delivery and Translational Research
    Article Open access 01 March 2024
  9. High-Throughput Identification of miRNA–Target Interactions in Melanoma Using miR-CATCHv2.0

    MicroRNAs (miRNAs) can regulate the expression of potentially every transcript in the cell, and the definition of miRNA–target interactions is...
    Andrea Marranci, Romina D’Aurizio, ... Laura Poliseno in Melanoma
    Protocol 2021
  10. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers

    Background

    p63, a member of the p53 gene family, is an important regulator for epithelial tissue growth and development. ∆Np63α is the main isoform of...

    Eid S. Alshammari, Amjad A. Aljagthmi, ... Weiwen Long in BMC Cancer
    Article Open access 12 February 2021
  11. Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

    There is a critical need for effective treatments for leptomeningeal disease (LMD). Here, we report the interim analysis results of an ongoing...

    Isabella C. Glitza Oliva, Sherise D. Ferguson, ... Michael A. Davies in Nature Medicine
    Article Open access 30 March 2023
  12. Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy

    Although immunotherapy has revolutionized cancer treatment, only a subset of patients demonstrate durable clinical benefit. Definitive predictive...

    Eva Pérez-Guijarro, Howard H. Yang, ... Glenn Merlino in Nature Medicine
    Article 13 April 2020
  13. Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells

    Background

    Circulating tumour cells (CTCs) can be assessed through a minimally invasive blood sample with potential utility as a predictive,...

    Carlos Alberto Aya-Bonilla, Michael Morici, ... Elin Solomonovna Gray in British Journal of Cancer
    Article Open access 10 February 2020
  14. Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies

    Background

    Melanoma is a cancer that has a high mortality rate in the absence of targeted therapy. Conventional therapies such as surgery,...

    Shaghayegh Haghjooy Javanmard, Golnaz Vaseghi, ... Reza Nedaeinia in Cancer Cell International
    Article Open access 10 August 2020
  15. BRAFi induced demethylation of miR-152-5p regulates phenotype switching by targeting TXNIP in cutaneous melanoma

    Treatment of advanced BRAF V600 -mutant melanoma using BRAF inhibitors (BRAFi) eventually leads to drug resistance and selects for highly metastatic...

    Kezhu Li, Mingrui Tang, ... Shifeng ** in Apoptosis
    Article 13 February 2020
  16. T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells

    Background

    Drug resistance remains as one of the major challenges in melanoma therapy. It is well known that tumour cells undergo phenotypic switching...

    Karol Granados, Laura Hüser, ... Jochen Utikal in British Journal of Cancer
    Article Open access 17 February 2020
  17. A method for predicting drugs that can boost the efficacy of immune checkpoint blockade

    Combination therapy is a promising therapeutic strategy to enhance the efficacy of immune checkpoint blockade (ICB); however, predicting drugs for...

    Yun **a, **n Li, ... An-Yuan Guo in Nature Immunology
    Article 18 March 2024
  18. Factor of time in dendritic cell (DC) maturation: short-term activation of DCs significantly improves type 1 cytokine production and T cell responses

    Dendritic cells (DCs) have been intensively studied in correlation to tumor immunology and for the development DC-based cancer vaccines. Here, we...

    Primož Poženel, Kaja Zajc, Urban Švajger in Journal of Translational Medicine
    Article Open access 06 June 2024
  19. DEHP (di(2-ethylhexyl)phthalate) stimulates skin pigmentation by perturbing cytoskeletal homeostasis

    Phthalates are extensively employed plasticizers crucial for conferring flexibility and plasticity to polyvinyl chloride. Phthalates, including DEHP...

    Minjeong Kim, Kyung-Min Lim in Toxicological Research
    Article 22 May 2024
  20. Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells

    Background

    Autologous dendritic cells (DC) loaded with tumor-associated antigens (TAAs) are a promising approach for anticancer immunotherapy....

    Anna Danilova, Vsevolod Misyurin, ... Irina Baldueva in Clinical Sarcoma Research
    Article Open access 04 February 2020
Did you find what you were looking for? Share feedback.